![Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5c2efb87-9088-4854-9aef-23fbfbd2413e/pds3958-fig-0002-m.jpg)
Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
![Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature - Marie-Laure Kürzinger, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, Stéphanie ... Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature - Marie-Laure Kürzinger, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, Stéphanie ...](https://journals.sagepub.com/cms/10.1177/2042098620976951/asset/images/large/10.1177_2042098620976951-fig1.jpeg)
Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature - Marie-Laure Kürzinger, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, Stéphanie ...
Good Enough Level is achieved by considering the ideal balance between... | Download Scientific Diagram
![Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4174ad5d-a116-4d0e-a93e-1a31658421f1/pds3958-fig-0005-m.jpg)